390 related articles for article (PubMed ID: 33106497)
1. Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients.
Lorenz G; Moog P; Bachmann Q; La Rosée P; Schneider H; Schlegl M; Spinner C; Heemann U; Schmid RM; Algül H; Lahmer T; Huber W; Schmaderer C
Sci Rep; 2020 Oct; 10(1):18277. PubMed ID: 33106497
[TBL] [Abstract][Full Text] [Related]
2. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
Soy M; Atagündüz P; Atagündüz I; Sucak GT
Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
[TBL] [Abstract][Full Text] [Related]
3. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
Opoka-Winiarska V; Grywalska E; Roliński J
BMC Med; 2020 Jul; 18(1):214. PubMed ID: 32664932
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis.
Prilutskiy A; Kritselis M; Shevtsov A; Yambayev I; Vadlamudi C; Zhao Q; Kataria Y; Sarosiek SR; Lerner A; Sloan JM; Quillen K; Burks EJ
Am J Clin Pathol; 2020 Sep; 154(4):466-474. PubMed ID: 32681166
[TBL] [Abstract][Full Text] [Related]
5. [Secondary hemophagocytic lymphohistiocytosis and cytokine release syndrome in COVID-19, the same or different entities?].
Alfaro-Murillo A; Lazo-Paéz G
Rev Chilena Infectol; 2021 Apr; 38(2):271-278. PubMed ID: 34184718
[TBL] [Abstract][Full Text] [Related]
6. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.
Tholin B; Hauge MT; Aukrust P; Fehrle L; Tvedt TH
J Med Case Rep; 2020 Oct; 14(1):187. PubMed ID: 33054818
[TBL] [Abstract][Full Text] [Related]
7. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
[TBL] [Abstract][Full Text] [Related]
8. Cytokine storm in severe COVID-19 pneumonia.
Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
[TBL] [Abstract][Full Text] [Related]
9. Cytokine release syndrome in severe COVID-19.
Moore JB; June CH
Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
[No Abstract] [Full Text] [Related]
10. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
Alunno A; Carubbi F; Rodríguez-Carrio J
RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.
Bhattacharjee S; Banerjee M; Pal R
Indian Pediatr; 2020 Sep; 57(9):827-833. PubMed ID: 32583809
[TBL] [Abstract][Full Text] [Related]
13. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
14. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
Yongzhi X
Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
[TBL] [Abstract][Full Text] [Related]
15. Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
Dimopoulos G; de Mast Q; Markou N; Theodorakopoulou M; Komnos A; Mouktaroudi M; Netea MG; Spyridopoulos T; Verheggen RJ; Hoogerwerf J; Lachana A; van de Veerdonk FL; Giamarellos-Bourboulis EJ
Cell Host Microbe; 2020 Jul; 28(1):117-123.e1. PubMed ID: 32411313
[TBL] [Abstract][Full Text] [Related]
16. Haemophagocytic syndrome and COVID-19.
Retamozo S; Brito-Zerón P; Sisó-Almirall A; Flores-Chávez A; Soto-Cárdenas MJ; Ramos-Casals M
Clin Rheumatol; 2021 Apr; 40(4):1233-1244. PubMed ID: 33389315
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
Amir R; Kichloo A; Singh J; Bhanot R; Aljadah M; Kumar A; Albosta MS; Solanki S
J Investig Med High Impact Case Rep; 2020; 8():2324709620950107. PubMed ID: 32787459
[TBL] [Abstract][Full Text] [Related]
18. The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19.
Loscocco GG; Malandrino D; Barchiesi S; Berni A; Poggesi L; Guglielmelli P; Vannucchi AM
Int J Lab Hematol; 2020 Dec; 42(6):e270-e273. PubMed ID: 32776691
[No Abstract] [Full Text] [Related]
19. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.
Bolondi G; Russo E; Gamberini E; Circelli A; Meca MCC; Brogi E; Viola L; Bissoni L; Poletti V; Agnoletti V
World J Emerg Surg; 2020 Jun; 15(1):41. PubMed ID: 32605582
[TBL] [Abstract][Full Text] [Related]
20. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease.
McGonagle D; Sharif K; O'Regan A; Bridgewood C
Autoimmun Rev; 2020 Jun; 19(6):102537. PubMed ID: 32251717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
